메뉴 건너뛰기




Volumn 11, Issue 1, 2004, Pages 9-10

Editorial: Hormone replacement therapy: A promoter and modulator of breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; DISEASE COURSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; NOTE; PATHOLOGY; TIME;

EID: 2142693207     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1007/BF02524338     Document Type: Editorial
Times cited : (3)

References (8)
  • 1
    • 2142743257 scopus 로고    scopus 로고
    • The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers
    • 10.1245/ASO.2004.03.012
    • I Pappo I Meirshon T Karni, et al. 2003 The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers Ann Surg Oncol 11 52 8 10.1245/ASO.2004.03.012
    • (2003) Ann Surg Oncol , vol.11 , pp. 52-8
    • Pappo, I.1    Meirshon, I.2    Karni, T.3
  • 2
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • DOI 10.1016/S0140-6736(97)08233-0
    • Collaborative Group on Hormone Factors for Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis from 51 individual epidemiological studies Lancet 350 1047 60 10.1016/S0140-6736(97) 08233-0 (Pubitemid 27437855)
    • (1997) Lancet , vol.350 , Issue.9084 , pp. 1047-1059
    • Beral, V.1
  • 3
    • 0031717805 scopus 로고    scopus 로고
    • Low biologic aggressiveness in breast cancer in women using hormone replacement therapy
    • 9738583 1:CAS:528:DyaK1cXmtFSlsLc%3D
    • K Holli J Isola J Cuzik 1998 Low biologic aggressiveness in breast cancer in women using hormone replacement therapy J Clin Oncol 16 3115 20 9738583 1:CAS:528:DyaK1cXmtFSlsLc%3D
    • (1998) J Clin Oncol , vol.16 , pp. 3115-20
    • Holli, K.1    Isola, J.2    Cuzik, J.3
  • 4
    • 0029056755 scopus 로고
    • The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
    • 7753136 1:STN:280:ByqB2s3msVQ%3D 10.1056/NEJM199506153322401
    • GA Colditz SE Hankinson DJ Hunter, et al. 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1589 93 7753136 1:STN:280:ByqB2s3msVQ%3D 10.1056/NEJM199506153322401
    • (1995) N Engl J Med , vol.332 , pp. 1589-93
    • Colditz, G.A.1    Hankinson, S.E.2    Hunter, D.J.3
  • 5
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women
    • Writing Group for the Women's Health Initiative Investigators. 10.1001/jama.288.3.321
    • Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women JAMA 288 321 33 10.1001/jama.288.3.321
    • (2002) JAMA , vol.288 , pp. 321-33
  • 6
    • 0032911246 scopus 로고    scopus 로고
    • Estrogen replacement therapy and breast cancer: Analysis of age of onset and tumor characteristics
    • 10082047 1:STN:280:DyaK1M7otVSrtg%3D%3D 10.1007/s10434-999-0200-7
    • MM Bilimoria DJ Winchester SF Sener G Motykie UL Sehgal DP Winchester 1999 Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics Ann Surg Oncol 6 200 7 10082047 1:STN:280: DyaK1M7otVSrtg%3D%3D 10.1007/s10434-999-0200-7
    • (1999) Ann Surg Oncol , vol.6 , pp. 200-7
    • Bilimoria, M.M.1    Winchester, D.J.2    Sener, S.F.3    Motykie, G.4    Sehgal, U.L.5    Winchester, D.P.6
  • 7
    • 0036778134 scopus 로고    scopus 로고
    • Tamoxifen: An update on current data and where it can now be used
    • 10.1023/A:1020353530963
    • L Wickerham 2002 Tamoxifen: an update on current data and where it can now be used Breast Cancer Res Treat 75 Suppl 1 7 12 10.1023/A:1020353530963
    • (2002) Breast Cancer Res Treat , vol.75 , Issue.SUPPL. 1 , pp. 7-12
    • Wickerham, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.